We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Synergism Antiproliferative Effects of Apigenin and Naringenin in NSCLC Cells.
- Authors
Liu, Xiongxiong; Zhao, Ting; Shi, Zheng; Hu, Cuilan; Li, Qiang; Sun, Chao
- Abstract
Non-small cell lung cancer (NSCLC) is one of the leading cancer killers. Apigenin (Api) and Naringenin (Nar) are natural bioactive substances obtained in various vegetables and fruits, possessing anti-tumor effects across multiple studies. This study investigated the latent synergistic antiproliferative functions of Api and Nar in A549 and H1299 NSCLC cells. Cell viability was determined after incubating with different concentrations of Api, Nar, or the combination of Api and Nar (CoAN) for 24 h. Analysis using the CompuSyn software revealed that the CI value of each combined dose was < 1, depicting that the two drugs had a synergistic inhibitory effect. The CoAN (A:N = 3:2) group with the lowest CI value was selected for subsequent experiments. The IC50 of CoAN (A:N = 3:2) was used to determine the cell cycle, the expression ratio of Bax to Bcl2, Caspase 3 activity, and mitochondrial function to assess oxidative stress and apoptosis. The results established that CoAN treatment caused significant cytotoxicity with cell cycle arrest at G2/M phases. Furthermore, CoAN significantly enhanced mitochondria dysfunction, elevated oxidative stress, and activated the apoptotic pathway versus Api or Nar alone groups. Thus, the CoAN chemotherapy approach is promising and deserves further research.
- Subjects
APIGENIN; NON-small-cell lung carcinoma; NARINGENIN; CELL cycle; INGESTION
- Publication
Molecules, 2023, Vol 28, Issue 13, p4947
- ISSN
1420-3049
- Publication type
Article
- DOI
10.3390/molecules28134947